3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Keratosis, Actinic
22
Carcinoma, Basal Cell
10
Uterine Cervical Dysplasia
7
Melanoma
7
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Precancerous Conditions
3
Keratosis
3
Glioma
3
Glioblastoma
3
Condylomata Acuminata
3
Urinary Bladder Neoplasms
2
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Hutchinson's Melanotic Freckle
2
HIV Infections
2
Astrocytoma
2
Warts
1
Vulvar Neoplasms
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sialorrhea
1
Sexually Transmitted Diseases
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Doxorubicin
15
Zidovudine
12
Vincristine
11
Bleomycin
10
Interferon alpha-2
6
Cyclophosphamide
5
tecogalan
4
sargramostim
4
Methotrexate
4
Liposomes
4
Leucovorin
4
Filgrastim
4
Etoposide
4
Dexamethasone
4
Cytarabine
4
Fluorouracil
3
interferon alfa-n1
2
Valganciclovir
2
Tumor Necrosis Factor-alpha
2
Thalidomide
2
Rituximab
2
Ritonavir
2
Nivolumab
2
Mitoxantrone
2
Isotretinoin
2
Interleukin-2
2
Electrocoagulation
2
Didanosine
2
Allopurinol
2
ziconotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Acquired Immunodeficiency Syndrome
×
Imiquimod
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts